[1]卞伟伟 黄斌 李军.开窍汤联合疏血通注射液改善急性脑梗死患者神经功能的临床效果及机制探讨[J].卒中与神经疾病杂志,2020,27(05):585-589.[doi:10.3969/j.issn.1007-0478.2020.05.006]
　Bian Weiwei*,Huang Bin,Li Jun..Clinical effect and mechanism of kaiqiao decoction combined with shuxuetong injection on improving nerve function in patients with acute cerebral infarction[J].Stroke and Nervous Diseases,2020,27(05):585-589.[doi:10.3969/j.issn.1007-0478.2020.05.006]
点击复制

开窍汤联合疏血通注射液改善急性脑梗死患者神经功能的临床效果及机制探讨()
分享到：

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第27卷
期数:
2020年05期
页码:
585-589
栏目:
论 著
出版日期:
2020-10-20

文章信息/Info

Title:
Clinical effect and mechanism of kaiqiao decoction combined with shuxuetong injection on improving nerve function in patients with acute cerebral infarction
文章编号:
1007-0478(2020)05-0585-05
作者:
卞伟伟 黄斌 李军
Author(s):
Bian Weiwei*;  Huang Bin;  Li Jun.
*Department of Neurology, Nanjing Jiangbei People's Hospital, Nantong University, Nanjing 210048
关键词:
开窍汤 疏血通注射液 急性脑梗死 神经功能 作用机制
Keywords:
Kaiqiao decoction Shuxuetong injection Acute cerebral infarction Neural function Mechanism of action
分类号:
R743.3
DOI:
10.3969/j.issn.1007-0478.2020.05.006
文献标志码:
A
摘要:
目的 观察开窍汤联合疏血通注射液改善急性脑梗死患者神经功能的临床效果及其可能的作用机制。方法 选择2018年6月-2019年6月本院收治的80例急性脑梗死患者,按照随机数字表分为对照组和观察组,每组各40例; 2组患者均给予常规治疗,对照组在常规治疗基础上给予疏血通注射液,观察组患者在对照组基础上加用开窍汤治疗,2周为1个疗程,连续用药2个疗程; 通过观察治疗前后神经功能缺损程度变化以评价临床治疗效果,并评价运动功能、日常生活能力,检测大脑动脉血流速度及血清中细胞凋亡、神经损伤相关指标水平变化。结果 与对照组的有效率75.00%(30/40)比较,观察组的有效率92.50%(37/40)显著升高(χ2=4.501,P<0.05); 观察组治疗2、4周后的NIHSS评分均显著低于对照组(P<0.05); 观察组治疗4周后的FMA评分、MBI评分显著高于对照组,即运动功能、日常生活能力提高更明显(P<0.05); 观察组患者治疗4周后的MCA,PCA,ACA,BA血灌速度显著高于对照组(P<0.05); 观察组治疗4周后的Caspase-3,H-FABP水平显著低于对照组,IGF-1,CGRP水平则显著高于对照组(P<0.05)。结论 开窍汤联合疏血通注射液更利于改善急性脑梗死患者的神经功能,提高运动功能、日常生活能力,其机制可能与增加脑血流灌注、抑制细胞凋亡、神经损伤以发挥脑保护作用有关。
Abstract:
ObjectiveTo observe the clinical effect and possible mechanism of kaiqiao decoction combined with shuxuetong injection on improving nerve function in patients with acute cerebral infarction.Methods Eighty patients with acute cerebral infarction admitted to our hospital from June 2018 to June 2019 were selected and divided into control group and observation group according to the random number table, with 40 patients in each group. Patients in both groups were treated with conventional western medicine. Patients in the control group were given shuxuetong injection on the basis of conventional intervention. Patients in the observation group were treated with kaiqiaotang on the basis of the control group. The clinical therapeutic effect was evaluated by observing the changes in the degree of neurological impairment before and after treatment, the changes in motor function and daily living ability were evaluated, and the changes in blood flow velocity of cerebral artery, the relative parameters of cell apoptosis and nerve injury in serum were detected.Results Compared with the control group, the effective rate of the observation group was 75.00%(30/40),the effective rate of the observation group was 92.50%(37/40)(χ2=4.501, P<0.05). The NIHSS scores of the observation group were significantly lower than those of the control group after 2 weeks of treatment and 4 weeks of treatment(P<0.05). After 4 weeks of treatment, the FMA score and MBI score of the observation group were significantly higher than those of the control group(P<0.05). After 4 weeks of treatment, the blood flow velocities of MCA, PCA, ACA and BA of the observation group after treatment were significantly higher than those of the control group(P<0.05). After 4 weeks of treatment, the serum levels of Caspase-3 and H-FABP in the observation group were significantly lower than those in the control group, while the serum levels of IGF-1 and CGRP in the observation group were significantly higher than those in the control group(P<0.05).Conclusion Kaiqiao decoction combined with shuxuetong injection was more conducive to improving the neurological function of patients with acute cerebral infarction, improving the motor function and the ability of daily living, and its mechanism might be related to increasing cerebral blood perfusion, inhibiting the apoptosis of nerve cells and damage to play the role of brain protection.

参考文献/References:

[1] Zhang H,Li CL,Wan F,et al.Efficacy of cattle encephalon glycoside and ignotin in patients with acute cerebral infarction:a randomized,double-blind,parallel-group,placebo-controlled study[J].Neural Regeneration Research,2020,15(7):1266-1273.
[2] Shuai J,Tian L,Ji T,et al.AMPK:potential therapeutic target for ischemic stroke[J].Theranostics,2018,8(16):4535-4551.
[3] 刘华.中医综合治疗缺血性脑卒中疗效的Meta分析[J].中西医结合心脑血管病杂志,2019,17(24):3898-3904.
[4] 国家中医药管理局脑病急症协作组.中风病诊断与疗效评定标准(试行)[J].北京中医药大学学报,1996,19(1):55-56.
[5] 中华医学会神经病学分会.中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2018[J].中华神经科杂志,2018,51(9):666-667.
[6] 中华神经科学会.中华神经外科学会.脑卒中患者临床神经功能缺损程度评分标准[J].中华神经科杂志,1996,29(6):381-383.
[7] 王玉龙.康复功能评定学[M].2版.北京:人民卫生出版社,2013:154-400.
[8] 孟胜喜,霍清萍,王兵,等.从痰瘀角度论治缺血性脑血管病[J].山东中医杂志,2015,34(10):733-735.
[9] 张敏,丁砚兵.痰瘀同治法治疗痰瘀阻络型急性脑梗死的疗效观察[J].湖北中医杂志,2014,36(10):32-33.
[10] 哈玲梅,杨丽荣,张赛,等.疏血通注射液联合阿替普酶治疗急性缺血性脑卒中的效果及对血液流变学的影响[J].中国医药,2020,15(3):378-382.
[11] 王玲,李江,徐少锋,等.人工麝香对大鼠急性脑缺血再灌损伤和脑出血的实验治疗[J].药学学报,2019,54(6):1036-1040.
[12] 李传朋,郭惟,秦秀德.红花注射液治疗脑血管疾病研究进展[J].中西医结合心脑血管病杂志,2018,16(10):1371-1374.
[13] 徐琳,洪福娣,赵维娟,等.丹参酮ⅡA对急性脑梗死模型大鼠脑组织Cyclin D1、GSK-3β和p-GSK-3β的影响[J].中国中医急症,2019,28(11):1925-1928.
[14] 王萍,闫东明,黄茜,等.三七总皂苷治疗缺血性脑卒中的神经保护机制[J].中国药理学通报,2018,34(12):1750-1755.
[15] 胡云芝,李军民,鲁之中,等.白茅苷对缺氧缺血性脑损伤模型新生大鼠心肌损伤和免疫反应的影响[J].免疫学杂志,2020,36(2):132-137.
[16] 赵辉,白玉彦,温桂莲,等.红景天苷对急性脑出血大鼠神经功能缺损评分与脑含水量的影响及其作用机制研究[J].中西医结合心脑血管病杂志,2019,17(3):368-371.
[17] 肖一鑫,章纪叶,刘佳奕,等.石菖蒲煎剂对不同时长急性脑缺血再灌注大鼠BBB保护效应的研究[J].成都中医药大学学报,2016,39(2):32-35.
[18] 付蓓蓓,郑永强,徐悦.黄芪甲苷改善大鼠急性脑梗死神经运动功能及对梗死侧大脑皮层中NF-κB p65及IKKβ蛋白的影响[J].中国中医急症,2019,28(1):25-28.
[19] 杨筱倩,丁煌,刘晓丹,等.冰片配伍黄芪甲苷和三七总皂苷促进脑缺血再灌注后神经修复作用的研究[J].中华中医药杂志,2019,34(12):5854-5859.
[20] 张艾嘉,王爽,王萍,等.缺血性脑卒中的病理机制研究进展及中医药防治[J].中国实验方剂学杂志,2020,26(5):227-240.
[21] 高峰,迟景宏,王欣平,等.急性脑梗死患者血清Caspase-3和神经元特异性烯醇化酶的表达及意义[J].中国老年学杂志,2018,38(1):73-75.
[22] 吴芳,刘悦,蔡志友.急性脑梗死患者神经功能缺损程度与血清H-FABP、CD62P水平的关系[J].卒中与神经疾病,2018,25(2):142-145, 149.
[23] 徐文文,廖庆红,王丽芳.电针对急性脑梗死患者脑血流动力学及血清bFGF、IGF-1的影响[J].上海针灸杂志,2019,38(9):969-972.
[24] 夏溪,赵杨,梁艳,等.平肝涤痰通络汤联合通脑活络针刺法治疗急性脑梗死及对神经功能的影响[J].世界中医药,2019,14(6):1564-1568.

备注/Memo

备注/Memo:
(2020-04-22收稿)基金项目:南通市卫生健康委员会科研项目(MB2019037)作者单位:210048 南京,南通大学附属南京江北人民医院神经内科(卞伟伟); 南京市浦口区中医院急诊科[黄斌(通信作者)]; 江苏省海安市人民医院神经内科(李军)
更新日期/Last Update: 2020-10-20